SureTrader
Home > Boards > US OTC > Biotechs > PharmaCyte Biotech Inc. (PMCB)

NVLX

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
NYC Trader Member Profile
 
Followed By 1,157
Posts 143,448
Boards Moderated 6
Alias Born 01/25/09
160x600 placeholder
Stonegate Capital Partners Publishes Research Report on PharmaCyte Biotech "GlobeNewswire Inc." - 2/10/2016 9:32:58 AM
Johnson & Johnson and Big Pharma Could Find a Diabetes "Cure" With PharmaCyte Biotech's Type 1 Diabetes Treatment "Marketwired" - 2/8/2016 9:00:00 AM
PharmaCyte Executives Meet With Translational Drug Development to Advance Pancreatic Cancer Clinical Trial "GlobeNewswire Inc." - 1/25/2016 9:25:00 AM
PharmaCyte Biotech Introduces Cell-in-a-Box as a Novel Treatment for Pancreatic Cancer and Potential Cure for Type 1 Diabetes... "GlobeNewswire Inc." - 1/19/2016 9:25:00 AM
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 1/19/2016 6:17:47 AM
Amended Quarterly Report (10-q/a) "Edgar (US Regulatory)" - 1/19/2016 6:16:25 AM
Amended Quarterly Report (10-q/a) "Edgar (US Regulatory)" - 1/19/2016 6:13:24 AM
Amended Annual Report (10-k/a) "Edgar (US Regulatory)" - 1/19/2016 6:10:54 AM
PharmaCyte Biotech Raises Additional $1 Million for Pancreatic Cancer Clinical Trial "GlobeNewswire Inc." - 1/14/2016 9:25:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/12/2016 5:17:52 PM
PharmaCyte Biotech to Attend J.P. Morgan Healthcare Conference "GlobeNewswire Inc." - 1/7/2016 9:00:00 AM
PharmaCyte Biotech Outlines 2016 Milestones as Its Pancreatic Cancer Treatment Moves Into a Clinical Trial "GlobeNewswire Inc." - 1/4/2016 8:45:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/31/2015 9:24:46 AM
PharmaCyte Biotech End of Year Shareholder Update on Pancreatic Cancer and Diabetes Programs "GlobeNewswire Inc." - 12/30/2015 9:00:00 AM
PharmaCyte Biotech Releases New Video Highlighting Diabetes Treatment Development Program "GlobeNewswire Inc." - 12/15/2015 9:25:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 12/10/2015 4:50:50 PM
PharmaCyte Biotech Provides Update on Malignant Ascites and New Colon Cancer Studies "GlobeNewswire Inc." - 12/7/2015 9:25:00 AM
PharmaCyte Contractor Chamow & Associates to Visit Cell-in-a-Box® Encapsulation Facility in Bangkok, Thailand "GlobeNewswire Inc." - 12/4/2015 9:25:00 AM
PharmaCyte Biotech Provides Link to Orphan Drug Designation for Its Pancreatic Cancer Treatment "GlobeNewswire Inc." - 11/24/2015 9:25:00 AM
PharmaCyte Biotech Announces Appointment of International Diabetes Expert to Scientific Advisory Board "GlobeNewswire Inc." - 11/19/2015 10:41:11 AM
PharmaCyte Biotech Appoints International Diabetes Expert to Its Scientific Advisory Board "GlobeNewswire Inc." - 11/19/2015 9:25:00 AM
PharmaCyte Biotech Obtains Orphan Drug Designation in Europe for Its Pancreatic Cancer Treatment "GlobeNewswire Inc." - 11/17/2015 9:22:24 AM
PharmaCyte Biotech Scientific Advisory Board Member Named Clinical Director of Prestigious Boston Cancer Center "GlobeNewswire Inc." - 11/10/2015 10:18:08 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/2/2015 4:15:41 PM
PharmaCyte Biotech Hosts 2nd Annual Meeting of International Diabetes Consortium Developing Novel Treatment for Diabetes "GlobeNewswire Inc." - 10/29/2015 9:20:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist